Markets:

Overview

News

Currencies

International

Treasuries

Greenwich LifeSciences, Inc. - Common stock (NQ:GLSI)

15.85 -0.05 (-0.31%)

Streaming Delayed Price Updated: 9:44 AM EDT, Sep 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Greenwich LifeSciences, Inc. - Common stock

< Previous 1 2 3 4 Next >

InvestorNewsBreaks – Greenwich LifeSciences, Inc. (NASDAQ: GLSI) Highlights Phase 3 Trial Progress and Expanded Study Design

July 21, 2026

Via Investor Brand Network

Why Is GLSI Stock Rising Today? ↗

March 17, 2026

Greenwich LifeSciences said its Phase III breast cancer immunotherapy trial, involving 250 patients, showed a recurrence rate of under 1% per year.

Via Stocktwits

Topics Economy Government

Greenwich LifeSciences Stock Jumps After FDA Update ↗

January 22, 2026

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) shares are trading higher after the company announced the Food and Drug Administration approved the use of its first commercially manufactured GP2 lot for the...

Via Benzinga

Stay updated with the stocks that are on the move in today's pre-market session. ↗

January 22, 2026

Via Chartmill

Insiders Buying Greenwich LifeSciences And 2 Other Stocks ↗

March 25, 2024

Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades.

Via Benzinga

Greenwich LifeSciences Inc. (NASDAQ: GLSI) Near the Top of Equities by Percentage Gain on 2/14

February 14, 2024

Via Investor Brand Network

Why Did Greenwich LifeSciences Stock Soar Pre-Market Today? ↗

January 22, 2026

The company disclosed that the Food and Drug Administration (FDA) has reviewed and authorized the use of its first commercially produced batch of the GP2 drug product in the ongoing FLAMINGO-01 trial.

Via Stocktwits

Keep an eye on the top gainers and losers in Monday's session. ↗

December 29, 2025

Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Why Did GLSI Stock Surge 25% Today? ↗

December 29, 2025

The company’s Board extended the lock-up on shares held by directors, officers, and pre-IPO investors through Sept. 30, 2026.

Via Stocktwits

On Thursday, there are stocks with unusual volume. Let's take a look. ↗

December 18, 2025

Let's have a look at the stocks with an unusual volume in today's session.

Via Chartmill

Why Is GLSI Stock Rising Today? ↗

December 15, 2025

Greenwich LifeSciences shares surged following the company’s announcement of positive results from its phase III clinical trial, FLAMINGO-01.

Via Stocktwits

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 10, 2025

Via Benzinga

Greenwich LifeSciences Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

June 27, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 01, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 02, 2025

Via Benzinga

Glancy Prongay & Murray LLP Announces Investigation of Greenwich LifeSciences, Inc. (GLSI)

January 17, 2025

From Glancy Prongay & Murray LLP

Via Business Wire

GLSI Stock Earnings: Greenwich LifeSciences Reported Results for Q2 2024 ↗

August 15, 2024

Greenwich LifeSciences just reported results for the second quarter of 2024.

Via InvestorPlace

Over $1M Bet On United Security Bancshares? Check Out These 3 Stocks Insiders Are Buying ↗

July 25, 2024

Via Benzinga

GLSI Stock Earnings: Greenwich LifeSciences Beats EPS for Q1 2024 ↗

May 20, 2024

GLSI stock results show that Greenwich LifeSciences beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 22, 2024

Via Benzinga

GLSI Stock Earnings: Greenwich LifeSciences Misses EPS for Q4 2023 ↗

April 15, 2024

GLSI stock results show that Greenwich LifeSciences missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

HC Wainwright & Co. Maintains Buy Rating for Greenwich LifeSciences: Here's What You Need To Know ↗

February 20, 2024

Via Benzinga

Why Greenwich Lifesciences (GLSI) Stock Is Skyrocketing ↗

February 14, 2024

Greenwich Lifesciences shares are trading higher by 30.6% Wednesday afternoon. The company provided an update on the Phase III clinical trial, Flamingo-01.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 21, 2023

Via Benzinga

$4.7 Million Bet On Tilly's? Check Out These 3 Stocks Insiders Are Buying ↗

January 11, 2023

Although US stocks closed higher on Tuesday, there were a few notable insider trades.

Via Benzinga

Greenwich LifeSciences Provides Year End Update

December 29, 2022

From Greenwich LifeSciences, Inc.

Via Business Wire

Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2023

December 01, 2022

From Greenwich LifeSciences, Inc.

Via Business Wire

Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday ↗

November 25, 2022

Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share.

Via Benzinga

Bitcoin Holder MicroStrategy And 4 More Short Squeeze Stocks That Could Soar This Week ↗

October 24, 2022

Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge move.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.